Page last updated: 2024-08-25

rosiglitazone and n-formylmethionine leucyl-phenylalanine

rosiglitazone has been researched along with n-formylmethionine leucyl-phenylalanine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adams, R; Al-Mosawi, A; Evans, M; Evans, SA; Roberts, AW; Singh, N; Thomas, AW; Webb, R	1

Other Studies

1 other study(ies) available for rosiglitazone and n-formylmethionine leucyl-phenylalanine

Article	Year
The PPAR-gamma activator, Rosiglitazone, inhibits actin polymerisation in monocytes: involvement of Akt and intracellular calcium. Biochemical and biophysical research communications, 2005, Jul-29, Volume: 333, Issue:2 Topics: Actins; Calcium; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Intracellular Fluid; Leukocytes, Mononuclear; N-Formylmethionine Leucyl-Phenylalanine; PPAR gamma; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rosiglitazone; Thiazolidinediones	2005

Article

Year

The PPAR-gamma activator, Rosiglitazone, inhibits actin polymerisation in monocytes: involvement of Akt and intracellular calcium.

Biochemical and biophysical research communications, 2005, Jul-29, Volume: 333, Issue:2

Topics: Actins; Calcium; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Intracellular Fluid; Leukocytes, Mononuclear; N-Formylmethionine Leucyl-Phenylalanine; PPAR gamma; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rosiglitazone; Thiazolidinediones

2005